Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maxime Jullien, Cyrille Touzeau & Philippe Moreau. (2021) Monoclonal antibodies as an addition to current myeloma therapy strategies. Expert Review of Anticancer Therapy 21:1, pages 33-43.
Read now
Read now
Peng Han, Peng Cao, Shan Hu, Kangle Kong, Yu Deng, Bo Zhao & Fan Li. (2020) Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche. Cancer Management and Research 12, pages 5857-5879.
Read now
Read now
Sabrina Trudel, Philippe Moreau & Cyrille Touzeau. (2019) Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients’ selection and perspective. OncoTargets and Therapy 12, pages 5813-5822.
Read now
Read now
Arnab Ghosh, Sham Mailankody, Sergio A. Giralt, C. Ola Landgren, Eric L. Smith & Renier J. Brentjens. (2018) CAR T cell therapy for multiple myeloma: where are we now and where are we headed?. Leukemia & Lymphoma 59:9, pages 2056-2067.
Read now
Read now
Massimo Martino, Anna Grazia Recchia, Giuseppe Console, Massimo Gentile, Michele Cimminiello, Giuseppe Alberto Gallo, Anna Ferreri, Virginia Naso, Giuseppe Irrera, Giuseppe Messina, Tiziana Moscato, Ernesto Vigna, Iolanda Donatella Vincelli & Fortunato Morabito. (2017) Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?. Expert Opinion on Orphan Drugs 5:11, pages 875-887.
Read now
Read now
Articles from other publishers (25)
Nor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, Shafini Mohamed Yusoff, Azlan Husin & Muhammad Farid Johan. (2023) Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review. Diagnostics 13:14, pages 2328.
Crossref
Crossref
Michael L. Kueht, Laxmi Priya Dongur, Muhammad A. Mujtaba & Matthew F. Cusick. (2023) Antibody Therapeutics as Interfering Agents in Flow Cytometry Crossmatch for Organ Transplantation. Journal of Personalized Medicine 13:6, pages 1005.
Crossref
Crossref
Yue Wu, Xiangjun Shi, Xinchen Yao & Xinru Du. (2023) Biological research on the occurrence and development of multiple myeloma and its treatment. Immunity, Inflammation and Disease 11:5.
Crossref
Crossref
Chak-Sum Ho, Kyle R. Putnam, Christine R. Peiter, Walter F. Herczyk, John A. Gerlach, Yee Lu, Erica L. Campagnaro, Kenneth J. Woodside & Matthew F. Cusick. (2022) Daratumumab Interferes with Allogeneic Crossmatch Impacting Immunological Assessment in Solid Organ Transplantation. Journal of Clinical Medicine 11:20, pages 6059.
Crossref
Crossref
Linqing Shi, Bo Chen, Tianyu Liu, Liqiang Li, Biao Hu, Chenzhen Li, Bing Jia & Fan Wang. (2022)
99m
Tc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression
. Molecular Pharmaceutics 19:7, pages 2583-2594.
Crossref
Crossref
Alan H B Wu, Chia-Ching Wang, Chui Mei Ong & Kara L Lynch. (2022) Adequate Antibody Response to COVID-19 Vaccine in Patients with Monoclonal Gammopathies and Light Chain Amyloidosis. Laboratory Medicine 53:3, pages 314-319.
Crossref
Crossref
Merve PAMUKCUOGLU, Nuran Ahu BAYSAL & Mehmet Sezgin PEPELER. (2021) The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio. The European Research Journal 7:6, pages 541-549.
Crossref
Crossref
Li-Chung Tsao, Jeremy Force & Zachary C. Hartman. (2021) Mechanisms of Therapeutic Antitumor Monoclonal Antibodies. Cancer Research 81:18, pages 4641-4651.
Crossref
Crossref
Yin Wang, Yanqing Li & Ye Chai. (2021) Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis. Journal of International Medical Research 49:8, pages 030006052110381.
Crossref
Crossref
James M. Lonie, Andrew P. Barbour & Riccardo Dolcetti. (2021) Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches. Cancer Treatment Reviews 98, pages 102219.
Crossref
Crossref
Milan Stoiljkovic, Tamas L. Horvath & Mihály Hajós. (2021) Therapy for Alzheimer’s disease: Missing targets and functional markers?. Ageing Research Reviews 68, pages 101318.
Crossref
Crossref
Nizar Joher, Marie Matignon & Philippe Grimbert. (2021) HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers. Frontiers in Immunology 12.
Crossref
Crossref
Le Li & Ying Wang. (2020) Recent updates for antibody therapy for acute lymphoblastic leukemia. Experimental Hematology & Oncology 9:1.
Crossref
Crossref
Bernd Gruhn, Grit Brodt, Susan Wittig, Thomas Ernst & Jana Ernst. (2020) Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL. Annals of Hematology 99:5, pages 1133-1134.
Crossref
Crossref
Ilaria Saltarella, Vanessa Desantis, Assunta Melaccio, Antonio Giovanni Solimando, Aurelia Lamanuzzi, Roberto Ria, Clelia Tiziana Storlazzi, Maria Addolorata Mariggiò, Angelo Vacca & Maria Antonia Frassanito. (2020) Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. Cells 9:1, pages 167.
Crossref
Crossref
Omar Castaneda Puglianini & Nikolaos Papadantonakis. (2020) Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts. Therapeutic Advances in Hematology 11, pages 204062072092947.
Crossref
Crossref
Sheng Wang, Dexi Zhou, Zhenyu Xu, Jing Song, Xueyi Qian, Xiongwen Lv & Jiajie Luan. (2019) Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect. Current Drug Targets 20:11, pages 1180-1202.
Crossref
Crossref
Mika Hosokawa, Hirokazu Kashiwagi, Kotarosumitomo Nakayama, Mikiko Sakuragi, Mayumi Nakao, Tamayo Morikawa, Tomoko Kiyokawa, Hiroshi Aochi, Keisuke Nagamine, Hirohiko Shibayama & Yoshiaki Tomiyama. (2019) Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference. Transfusion 59:7, pages 2479-2480.
Crossref
Crossref
Lauren M. Moore, Sun Cho & Katie L. Thoren. (2019) MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins. Clinica Chimica Acta 492, pages 91-94.
Crossref
Crossref
Julian Boix-Vilanova, Jose María Sánchez, Aniza Giacaman & Adriana Quintero. (2019) Lesiones cutáneas secundarias a daratumumab. Piel 34:4, pages 212-214.
Crossref
Crossref
Hind Rafei, Faysal Haroun & Imad A. Tabbara. (2019) Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma. American Journal of Clinical Oncology 42:3, pages 317-329.
Crossref
Crossref
Alberto Aimo, Gabriele Buda, Marianna Fontana, Andrea Barison, Giuseppe Vergaro, Michele Emdin & Giampaolo Merlini. (2018) Therapies for cardiac light chain amyloidosis: An update. International Journal of Cardiology 271, pages 152-160.
Crossref
Crossref
Sophia Danhof, Michael Hudecek & Eric L. Smith. (2018) CARs and other T cell therapies for MM: The clinical experience. Best Practice & Research Clinical Haematology 31:2, pages 147-157.
Crossref
Crossref
Jennifer G Gaultney, Therese W Ng, Carin A Uyl-de Groot, Pieter Sonneveld, Erik H van Beers, Martin H van Vliet & William K Redekop. (2018) Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe. Pharmacogenomics 19:3, pages 213-226.
Crossref
Crossref
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Crossref